retatrutide safety trials ⚠️ “RETA” is NOT an approved weight-loss medication. Social media is full of “RETA” offers—but here's what you should know. is a promising investigational medicine developed by Eli Lilly. The Phase Retatrutide for Weight Loss: TRIUMPH-1

For Continuing Therapy If you are already on Zepbound: A renewal PA is required at 29 weeks After that, PAs are required every 12 months You must generally demonstrate a 5% reduction in weight from your baseline Important Clarification for Members Switching from Another GLP-1 If you are continuing therapy on a GLP-1 weight loss medication other than Zepbound, such as Wegovy: even if your BMI is now below 30, if you have lost 5% or more of your baseline weight, you may still meet prior authorization criteria for Zepbound under continuation-of-therapy guidelines

Biological Activities and Modern Pharmaceutical Forms

n = 4,668) or placebo ( n = 4,672), with both groups also receiving standard care (treatment period: 3.55 years)

Clinicians and prescribers should proactively discuss protein sources that patients are likely to tolerate, including dairy-based options and plant proteins, and consider whether supplementation is appropriate on an individual basis

The providers really dont know how to use these drugs properly

This move makes it easier and more cost-effective for people to get this popular weight-loss drug